Published in Philos Trans A Math Phys Eng Sci on November 28, 2011
Diffuse optical imaging using spatially and temporally modulated light. J Biomed Opt (2012) 1.55
Tissue phantoms in multicenter clinical trials for diffuse optical technologies. Biomed Opt Express (2012) 1.09
Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy. IEEE J Sel Top Quantum Electron (2011) 1.05
Adaptable near-infrared spectroscopy fiber array for improved coupling to different breast sizes during clinical MRI. Acad Radiol (2014) 1.01
Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer. Invest Radiol (2015) 0.99
Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system. Biomed Opt Express (2013) 0.91
Optically measured microvascular blood flow contrast of malignant breast tumors. PLoS One (2014) 0.90
Broadband optical mammography: chromophore concentration and hemoglobin saturation contrast in breast cancer. PLoS One (2015) 0.88
Automatic and robust calibration of optical detector arrays for biomedical diffuse optical spectroscopy. Biomed Opt Express (2012) 0.85
Optical malignancy parameters for monitoring progression of breast cancer neoadjuvant chemotherapy. Biomed Opt Express (2012) 0.85
Interplay between up-regulation of cytochrome-c-oxidase and hemoglobin oxygenation induced by near-infrared laser. Sci Rep (2016) 0.82
Evolutionary game theory for physical and biological scientists. II. Population dynamics equations can be associated with interpretations. Interface Focus (2014) 0.82
Anthropomorphic breast phantoms with physiological water, lipid, and hemoglobin content for near-infrared spectral tomography. J Biomed Opt (2014) 0.82
Towards non-invasive characterization of breast cancer and cancer metabolism with diffuse optics. PET Clin (2013) 0.81
In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab. Br J Cancer (2016) 0.81
Wearable near-infrared optical probe for continuous monitoring during breast cancer neoadjuvant chemotherapy infusions. J Biomed Opt (2017) 0.81
The clinical evaluation of novel imaging methods for cancer management. Nat Rev Clin Oncol (2012) 0.80
Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging. Cancer Res (2016) 0.79
Normalization of compression-induced hemodynamics in patients responding to neoadjuvant chemotherapy monitored by dynamic tomographic optical breast imaging (DTOBI). Biomed Opt Express (2017) 0.77
Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma. Ann Surg Oncol (2013) 0.77
Multiparametric monitoring of chemotherapy treatment response in locally advanced breast cancer using quantitative ultrasound and diffuse optical spectroscopy. Oncotarget (2016) 0.76
Mapping breast cancer blood flow index, composition, and metabolism in a human subject using combined diffuse optical spectroscopic imaging and diffuse correlation spectroscopy. J Biomed Opt (2017) 0.76
Effects of breast density and compression on normal breast tissue hemodynamics through breast tomosynthesis guided near-infrared spectral tomography. J Biomed Opt (2016) 0.75
Optical mammography: bilateral breast symmetry in hemoglobin saturation maps. J Biomed Opt (2016) 0.75
On the geometry dependence of differential pathlength factor for near-infrared spectroscopy. I. Steady-state with homogeneous medium. J Biomed Opt (2015) 0.75
Differential diagnosis of breast masses in South Korean premenopausal women using diffuse optical spectroscopic imaging. J Biomed Opt (2016) 0.75
Chemotherapeutic drug-specific alteration of microvascular blood flow in murine breast cancer as measured by diffuse correlation spectroscopy. Biomed Opt Express (2016) 0.75
Vertical-cavity surface-emitting laser sources for gigahertz-bandwidth, multiwavelength frequency-domain photon migration. J Biomed Opt (2017) 0.75
Value of combining dynamic contrast enhanced ultrasound and optoacoustic tomography for hypoxia imaging. Photoacoustics (2017) 0.75
Predicting breast cancer response to neoadjuvant chemotherapy using pretreatment diffuse optical spectroscopic texture analysis. Br J Cancer (2017) 0.75
Optical Mammography in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: Individual Clinical Response Index. Acad Radiol (2017) 0.75
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol (1998) 9.32
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol (2007) 7.00
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol (1997) 6.35
Multiple comparisons: philosophies and illustrations. Am J Physiol Regul Integr Comp Physiol (2000) 5.79
In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt (2006) 4.71
Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia (2000) 4.42
Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy. Proc Natl Acad Sci U S A (2007) 3.27
Assessing the future of diffuse optical imaging technologies for breast cancer management. Med Phys (2008) 3.02
Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI. Med Phys (2005) 2.76
Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes. Radiology (2009) 2.45
Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer (2002) 2.18
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. J Clin Oncol (2006) 2.12
Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study. J Biomed Opt (2004) 2.12
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J Nucl Med (2003) 2.06
MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol (2005) 2.06
Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol (2005) 2.05
Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T. Radiology (2004) 1.95
Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed (2009) 1.91
Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. J Nucl Med (2002) 1.87
Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer. Clin Cancer Res (2010) 1.63
Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol (2008) 1.60
Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. Radiology (2006) 1.60
Biomarkers in imaging: realizing radiology's future. Radiology (2003) 1.54
American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome. J Natl Cancer Inst (2005) 1.49
Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization. Neoplasia (2008) 1.45
Identification and quantification of intrinsic optical contrast for near-infrared mammography. Photochem Photobiol (1998) 1.43
Combined diffuse optical spectroscopy and contrast-enhanced magnetic resonance imaging for monitoring breast cancer neoadjuvant chemotherapy: a case study. J Biomed Opt (2005) 1.36
Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology (2009) 1.34
Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography. Cancer (1999) 1.33
Comparison of water and lipid content measurements using diffuse optical spectroscopy and MRI in emulsion phantoms. Technol Cancer Res Treat (2003) 1.24
MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol (2001) 1.22
18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer. Eur J Nucl Med Mol Imaging (2009) 1.20
Characterization of metabolic differences between benign and malignant tumors: high-spectral-resolution diffuse optical spectroscopy. Radiology (2010) 1.19
Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI. J Magn Reson Imaging (2009) 1.19
Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br J Cancer (2004) 1.18
Research issues affecting preoperative systemic therapy for operable breast cancer. J Clin Oncol (2008) 1.18
Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy. NMR Biomed (1998) 1.13
Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient. Acad Radiol (2010) 1.09
Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival. Cancer (2005) 1.09
Detection and characterization of optical inhomogeneities with diffuse photon density waves: a signal-to-noise analysis. Appl Opt (1997) 1.09
Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response. Lancet Oncol (2006) 1.08
Diffuse optical spectroscopy measurements of healing in breast tissue after core biopsy: case study. J Biomed Opt (2009) 1.03
Monitoring therapeutic efficacy in breast carcinomas. Eur Radiol (2006) 1.03
Magnetic resonance as a cancer imaging biomarker. J Clin Oncol (2006) 1.01
Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma. Cancer (1999) 0.96
Preoperative [18F] FDG-PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology. Ann Oncol (2008) 0.95
High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer. Breast Cancer Res Treat (2005) 0.94
Improved quantification of small objects in near-infrared diffuse optical tomography. J Biomed Opt (2004) 0.92
Effect of contact force on breast tissue optical property measurements using a broadband diffuse optical spectroscopy handheld probe. Appl Opt (2009) 0.90
Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directions. J Clin Oncol (2008) 0.89
Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer. Ann Surg (2009) 0.87
Trastuzumab in inflammatory breast cancer. Ann Oncol (2008) 0.83
Comparison of breast density in the contralateral normal breast of patients with invasive and in situ breast cancer measured on MRI. Ann Oncol (2009) 0.77
Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst (2006) 6.41
Quantitation and mapping of tissue optical properties using modulated imaging. J Biomed Opt (2009) 4.89
Imaging cells and extracellular matrix in vivo by using second-harmonic generation and two-photon excited fluorescence. Proc Natl Acad Sci U S A (2002) 4.73
In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt (2006) 4.71
Bevacizumab added to neoadjuvant chemotherapy for breast cancer. N Engl J Med (2012) 4.10
Modulated imaging: quantitative analysis and tomography of turbid media in the spatial-frequency domain. Opt Lett (2005) 3.82
Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy. Proc Natl Acad Sci U S A (2007) 3.27
Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007. Acta Oncol (2013) 2.84
Noninvasive assessment of collagen gel microstructure and mechanics using multiphoton microscopy. Biophys J (2006) 2.71
Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Res (2005) 2.68
Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax (2013) 2.19
Three-dimensional surface profile intensity correction for spatially modulated imaging. J Biomed Opt (2009) 2.18
Imaging coronary artery microstructure using second-harmonic and two-photon fluorescence microscopy. Biophys J (2004) 2.14
Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study. J Biomed Opt (2004) 2.12
"We are all in this together": integrated health service plans in Ontario. Healthc Q (2007) 2.08
Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy. J Biomed Opt (2007) 2.01
Image correlation spectroscopy of multiphoton images correlates with collagen mechanical properties. Biophys J (2007) 1.96
Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab. Ann Surg Oncol (2009) 1.80
Quantitative optical tomography of sub-surface heterogeneities using spatially modulated structured light. Opt Express (2009) 1.73
Noninvasive imaging of angiotensin receptors after myocardial infarction. JACC Cardiovasc Imaging (2008) 1.67
Reversible dissociation of collagen in tissues. J Invest Dermatol (2003) 1.64
Self-assembled virus-membrane complexes. Nat Mater (2004) 1.63
Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment. Proc Natl Acad Sci U S A (2011) 1.62
Combined multiphoton microscopy and optical coherence tomography using a 12-fs broadband source. J Biomed Opt (2006) 1.61
X-inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected. J Cell Physiol (2008) 1.59
Diffuse optical imaging using spatially and temporally modulated light. J Biomed Opt (2012) 1.55
Effect of excitation wavelength on penetration depth in nonlinear optical microscopy of turbid media. J Biomed Opt (2009) 1.54
Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership. Int J Cancer (2012) 1.54
Fiber delivered probe for efficient CARS imaging of tissues. Opt Express (2010) 1.54
Selective corneal imaging using combined second-harmonic generation and two-photon excited fluorescence. Opt Lett (2002) 1.52
A comparison of Doppler optical coherence tomography methods. Biomed Opt Express (2012) 1.52
Pathological complete response in triple negative poorly differentiated invasive ductal breast carcinoma detected during pregnancy. J Clin Oncol (2007) 1.51
First-in-human pilot study of a spatial frequency domain oxygenation imaging system. J Biomed Opt (2011) 1.50
Structured illumination enhances resolution and contrast in thick tissue fluorescence imaging. J Biomed Opt (2010) 1.49
Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. Gynecol Oncol (2012) 1.49
In vivo quantification of optical contrast agent dynamics in rat tumors by use of diffuse optical spectroscopy with magnetic resonance imaging coregistration. Appl Opt (2003) 1.46
MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer (2008) 1.44
Spatial variations in optical and physiological properties of healthy breast tissue. J Biomed Opt (2004) 1.42
Leadership development for early career doctors. Lancet (2012) 1.40
Miniaturized probe based on a microelectromechanical system mirror for multiphoton microscopy. Opt Lett (2008) 1.39
Wavelength optimization for rapid chromophore mapping using spatial frequency domain imaging. J Biomed Opt (2011) 1.36
Combined diffuse optical spectroscopy and contrast-enhanced magnetic resonance imaging for monitoring breast cancer neoadjuvant chemotherapy: a case study. J Biomed Opt (2005) 1.36
Effect of pulse duration on two-photon excited fluorescence and second harmonic generation in nonlinear optical microscopy. J Biomed Opt (2006) 1.36
Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues. In Vitro Cell Dev Biol Anim (2010) 1.35
Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology (2009) 1.34
Imaging cortical absorption, scattering, and hemodynamic response during ischemic stroke using spatially modulated near-infrared illumination. J Biomed Opt (2009) 1.32
Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy. Cancer Res (2012) 1.28
Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox. J Clin Oncol (2008) 1.27
Spatial shift of spatially modulated light projected on turbid media. J Opt Soc Am A Opt Image Sci Vis (2008) 1.26
Design and implementation of fiber-based multiphoton endoscopy with microelectromechanical systems scanning. J Biomed Opt (2009) 1.26
Epithelial-derived TGF-beta2 modulates basal and wound-healing subepithelial matrix homeostasis. Am J Physiol Lung Cell Mol Physiol (2006) 1.25
Characterization of cholesterol crystals in atherosclerotic plaques using stimulated Raman scattering and second-harmonic generation microscopy. Biophys J (2012) 1.25
The role of diffuse optical spectroscopy in the clinical management of breast cancer. Dis Markers (2004) 1.24
Imaging wound healing using optical coherence tomography and multiphoton microscopy in an in vitro skin-equivalent tissue model. J Biomed Opt (2004) 1.23
EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment. Mol Cancer (2011) 1.22
Imaging findings of cochlear nerve deficiency. AJNR Am J Neuroradiol (2002) 1.22
Three-dimensional speckle suppression in Optical Coherence Tomography based on the curvelet transform. Opt Express (2010) 1.21
Non-invasive in vivo diffuse optical spectroscopy monitoring of cyanide poisoning in a rabbit model. Physiol Meas (2007) 1.20
Speckle attenuation in optical coherence tomography by curvelet shrinkage. Opt Lett (2009) 1.19
Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging. J Lipid Res (2011) 1.19
Characterization of metabolic differences between benign and malignant tumors: high-spectral-resolution diffuse optical spectroscopy. Radiology (2010) 1.19
Quantitative spectroscopy of superficial turbid media. Opt Lett (2005) 1.17
Multispectral imaging of tissue absorption and scattering using spatial frequency domain imaging and a computed-tomography imaging spectrometer. J Biomed Opt (2011) 1.17
Imaging subcellular scattering contrast by using combined optical coherence and multiphoton microscopy. Opt Lett (2007) 1.16
Spectral discrimination of breast pathologies in situ using spatial frequency domain imaging. Breast Cancer Res (2013) 1.16
Place of residence and risk of fracture in older people: a population-based study of over 65-year-olds in Cardiff. Osteoporos Int (2003) 1.15
Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients. Gynecol Oncol (2002) 1.15
Developing compact multiphoton systems using femtosecond fiber lasers. J Biomed Opt (2009) 1.14
Rotational multiphoton endoscopy with a 1 microm fiber laser system. Opt Lett (2009) 1.13
In vivo multiphoton NADH fluorescence reveals depth-dependent keratinocyte metabolism in human skin. Biophys J (2013) 1.13
MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. J Magn Reson Imaging (2007) 1.13
Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry. Breast Cancer Res (2009) 1.12
Hemoglobin measurement patterns during noninvasive diffuse optical spectroscopy monitoring of hypovolemic shock and fluid replacement. J Biomed Opt (2007) 1.12
Nonlinear optical microscopy of articular cartilage. Osteoarthritis Cartilage (2005) 1.12
Multimodal CARS microscopy determination of the impact of diet on macrophage infiltration and lipid accumulation on plaque formation in ApoE-deficient mice. J Lipid Res (2010) 1.10
Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy. Breast Cancer Res (2013) 1.09
Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient. Acad Radiol (2010) 1.09
Tissue phantoms in multicenter clinical trials for diffuse optical technologies. Biomed Opt Express (2012) 1.09
Targeted spinal cord therapeutics delivery: stabilized platform and microelectrode recording guidance validation. Stereotact Funct Neurosurg (2007) 1.08
Use of an oxygen-carrying blood substitute to improve intravascular optical coherence tomography imaging. J Biomed Opt (2009) 1.07